ceritinib (LDK378)

ceritinib · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ceritinib (LDK378), covering 2017-02-01 to 2017-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies [Phase 2]